Related Experiment Video
Updated: Mar 16, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Potential Linkage Between Cerebrovascular Diseases and Metabolic Syndrome
Nasimudeen R Jabir, Chelapram Kandy Firoz, Mohd Shahnawaz Khan
1King Fahd Medical Research Center, King Abdulaziz University, P.O. Box 80216, Jeddah 21589, Saudi Arabia.
Insights
Cerebrovascular disease (CD) and metabolic syndrome (MetS) share common pathological pathways, including insulin resistance and hypertension. Targeting these shared mechanisms with novel drugs may offer effective treatment strategies for both conditions.
Area of Science:
- Cardiovascular Science
- Metabolic Disorders
- Neurology
Background:
- Cerebrovascular disease (CD) and metabolic syndrome (MetS) are significant global health issues contributing to mortality and disability.
- These conditions often co-exist and share mechanistic similarities, exacerbating pathological processes.
- Modifiable risk factors present in both CD and MetS highlight the potential for therapeutic intervention.
Purpose of the Study:
- To summarize common pathological conditions linking CD and MetS.
- To advocate for the development of common treatment strategies targeting shared molecular pathways.
- To explore the potential of multi-targeted drug discovery for managing these interconnected diseases.
Main Methods:
- Review and synthesis of existing scientific data on the mechanistic links between CD and MetS.
- Identification of shared pathological conditions such as abdominal obesity, insulin resistance, dyslipidemia, hypertension, and endothelial dysfunction.
- Analysis of therapeutic implications of targeting common pathways.
Main Results:
- Abdominal obesity, insulin resistance, dyslipidemia, hypertension, and endothelial dysfunction are identified as key common pathological conditions.
- These shared factors significantly worsen the homeostasis in individuals with CD and MetS.
- The co-existence of CD and MetS amplifies the risk of severe health events.
Conclusions:
- Developing common treatment strategies for CD and MetS is a promising therapeutic avenue.
- Common molecular agents targeting shared pathways could be effective.
- Advancement in novel multi-targeted drug discovery is crucial for preventing fatal complications of CD and MetS.
Abstract:
Cerebrovascular disease (CD) and metabolic syndrome (MetS) are two devastating health dilemma that continues to be a potential contributor to disability and mortality in human population all across the world. Scientific data clearly shows several mechanistic similarities between these two co-existing and interlinked conditions. The linkage exacerbates ongoing patho-physiological condition towards more lethal events. In view of the presence of modifiable risk factors in both CD and MetS, their management holds potential therapeutic value. Hence, developing common treatment strategies for these diseases could involve common molecular agents. In this communication, we have summarized some of the common pathological conditions viz. abdominal obesity, insulin resistance, dyslipidemia, hypertension, and endothelial dysfunction that further deteriorate existing homeostasis in CD and MetS. Based on our article, it is advocated that substantial improvements in novel multi-targeted drug discovery could provide the effective treatment methods in order to avoid the fatal complications related with CD and MetS.
More Related Videos
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
07:30Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Related Concept Videos
Coronary Artery Disease I: Introduction
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...